President Trump's administration has paused proposed funding cuts to the NIH, while researchers remain concerned about the long-term impact. The cuts, including a cap on indirect costs, could slow down medical research, hinder the development of new treatments, and weaken the U.S.'s position in global healthcare innovation. Experts express that increased reliance on private and nonprofit funding may be necessary for continuity in research. Paradoxically, some anticipate that the chaos could lead to faster grant processes and improved funding efficiency amid funding uncertainties.
The Trump administration's funding cuts to NIH, especially the cap on indirect costs, are expected to significantly disrupt the pace of medical research in the U.S.
Amid funding challenges, healthcare experts warn that the U.S. risks falling behind in healthcare innovation and commercialization of potentially groundbreaking treatments.
Healthcare researchers may need to increasingly rely on private industry and nonprofit funding to compensate for the cuts, affecting the future of medical advancements.
Collection
[
|
...
]